Cargando…
Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR)
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292333/ http://dx.doi.org/10.1186/2051-1426-2-S3-P187 |
| _version_ | 1782352476268134400 |
|---|---|
| author | Singh, Charu |
| author_facet | Singh, Charu |
| author_sort | Singh, Charu |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4292333 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42923332015-01-15 Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR) Singh, Charu J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292333/ http://dx.doi.org/10.1186/2051-1426-2-S3-P187 Text en Copyright © 2014 Singh; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Singh, Charu Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR) |
| title | Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR) |
| title_full | Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR) |
| title_fullStr | Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR) |
| title_full_unstemmed | Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR) |
| title_short | Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR) |
| title_sort | gefitinib in treatment of metastatic non-small cell lung cancer (nsclc) with mutated epidermal growth factor receptor (egfr) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292333/ http://dx.doi.org/10.1186/2051-1426-2-S3-P187 |
| work_keys_str_mv | AT singhcharu gefitinibintreatmentofmetastaticnonsmallcelllungcancernsclcwithmutatedepidermalgrowthfactorreceptoregfr |